Skip to main content
. 2019 Sep 18;76(12):1285–1293. doi: 10.1001/jamapsychiatry.2019.2499

Figure 4. Comparison of Toxoplasma gondii IgG and IgM Distributions Stratified by Use of Treatment With Antitoxoplasmic Activity (TATA).

Figure 4.

Case patients receiving TATA-positive medications had significantly lower T gondii IgM titers than did those not receiving TATA-positive medications (P = .02). There was no significant difference in T gondii IgG titers between the 2 groups (P = .45).